Compare Globus Medical Inc. Class A Common Stock (GMED) vs M&T Bank Corporation (MTB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs M&T Bank Corporation — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while M&T Bank Corporation trades at $215.86 (market cap $31.20B). The key difference: M&T Bank Corporation is far larger — about 3× Globus Medical Inc. Class A Common Stock's market cap, and M&T Bank Corporation pays a 2.78% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and M&T Bank Corporation for 99 Days on average.
| GMED | MTB | |
|---|---|---|
Market Cap | $10.25B | $31.20B |
Volume | 1,059,528 | 795,459 |
Sector | Health | Financials |
52-Week High | $96.82 | $254.09 |
52-Week Low | $58.33 | $178.63 |
Typical Hold Time | 0 Days | 99 Days |
Enterprise Value | $9.76B | $47.44B |
Dividend Yield | — | 2.78% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
M&T Bank (MTB) trades at $217.93, down 0.89% on the day, with a bearish technical signal and neutral oscillators. The stock shows strong fundamentals with a P/E of 11.54, net income margin of 30.85%, and three consecutive quarterly EPS beats. Recent news highlights loan growth, AI investments, and a new branch opening, while the company maintains a consistent dividend.
Outlook is cautiously optimistic given solid profitability and analyst consensus, but risks include negative net cash flow trends and elevated debt levels. The consensus price target of $256.62 suggests potential upside, contingent on continued earnings momentum and stable interest rate environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →
